Quest Diagnostics is a family of 2 companies that won 32 public contracts in 6 countries, headed by QUEST DIAGNOSTICS INCORPORATED (United States). Its companies' largest customer is Department of Justice - Federal Prison System / Bureau of Prisons (8 contracts). Latest award: Mar 2026.
Won by Blueprint Genetics Oy · awarded by Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke - CHUS · Canada · C$58,650
21 Mar 2023Awarded
Tests Genetiques Hors Quebec
Won by Blueprint Genetics Oy · awarded by Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke - CHUS · Canada · C$118,000
20 Apr 2022Awarded
Contract award
Won by Blueprint Genetics Oy · awarded by Azienda Unita' Sanitaria Locale DI Reggio Emilia · Italy · €210,000
4 Oct 2021Awarded
Tests laboratoire génétique
Won by Blueprint Genetics Oy · awarded by Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke - CHUS · Canada · C$96,200
Won by Blueprint Genetics Oy · awarded by Helsinki and Uusimaa Joint Municipal Authority for Specialised Health Care · Finland
8 May 2020Awarded
Contracts won by year
Contracts won by year
from the published records
20204
20212
20221
202310
20245
20256
20262
Published value, by currency
USD · 17 valued
$3.5 million
CAD · 6 valued
C$2.01 million
EUR · 4 valued
€1.94 million
The family adds up the public contract awards of every company below. Who belongs to the family comes from GLEIF, the global register of legal entities (Legal Entity Identifier 8MCWUBXQ0WE04KMXBX50, accounting consolidation); 0 companies were matched by registry number and the rest by exact legal name in their country. Each currency is shown on its own and never converted.
Bid with askTender
Bidding against Quest Diagnostics?
askTender reads any open tender against your company profile — eligibility, the gaps, and the documents you need — and can prepare the entire bid.